Position in CRON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,576,598
+$5,454,849 QoQ
Shares Held
8,840,503
+16.0% QoQ
Ownership
2.40%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 192 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in CRON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. CRON ranks #9 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in CRON
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,576,598 | 8,840,503 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,121,749 | 7,618,227 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,040,321 | 6,859,438 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,763,500 | 3,871,763 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,520,669 | 796,162 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $268,946 | 148,589 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $311,403 | 154,160 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $264,114 | 120,600 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $329,695 | 141,500 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $603,171 | 231,100 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $802,142 | 383,800 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,555,776 | 777,888 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,866,290 | 1,454,970 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,773,380 | 1,945,042 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,634,237 | 2,218,204 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,917,640 | 2,807,674 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,582,464 | 3,043,427 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,562,072 | 2,201,047 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,465,430 | 2,669,753 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,377,613 | 2,010,179 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,086,096 | 1,289,081 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,912,941 | 1,153,588 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,166,332 | 1,176,705 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,837,955 | 766,059 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,980,507 | 2,492,597 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,288,264 | 1,638,142 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||